Elena De Mattia Selected Research

Liver Neoplasms (Liver Cancer)

9/2017

Genetic biomarkers for hepatocellular cancer risk in a caucasian population.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Elena De Mattia Research Topics

Disease

24	Neoplasms (Cancer) 01/2022 - 09/2008
14	Colorectal Neoplasms (Colorectal Cancer) 06/2022 - 05/2009
6	Rectal Neoplasms (Rectal Cancer) 01/2022 - 04/2016
4	Inflammation (Inflammations) 04/2021 - 01/2018
4	Hepatocellular Carcinoma (Hepatoma) 01/2020 - 01/2017
3	Ovarian Neoplasms (Ovarian Cancer) 01/2020 - 01/2019
2	Ovarian Epithelial Carcinoma 01/2020 - 05/2018
2	Neutropenia 01/2018 - 06/2017
1	Breast Neoplasms (Breast Cancer) 09/2020
1	Melanoma (Melanoma, Malignant) 01/2020
1	Neoplasm Metastasis (Metastasis) 01/2020
1	Neuroblastoma 01/2020
1	Sarcoma (Soft Tissue Sarcoma) 01/2020
1	Brain Neoplasms (Brain Tumor) 01/2020
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2020
1	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 01/2020
1	Prostatic Neoplasms (Prostate Cancer) 04/2019
1	Peripheral Nervous System Diseases (PNS Diseases) 01/2018
1	Liver Neoplasms (Liver Cancer) 09/2017
1	Carcinoma (Carcinomatosis) 01/2016
1	Drug-Related Side Effects and Adverse Reactions 01/2016
1	Alopecia (Baldness) 12/2014
1	Hyperplasia 12/2014
1	Osteosarcoma (Osteogenic Sarcoma) 05/2009
1	Rheumatoid Arthritis 09/2008

Drug/Important Bio-Agent (IBA)

7	Pharmaceutical PreparationsIBA 06/2022 - 01/2016
7	Irinotecan (Camptosar)FDA LinkGeneric 04/2021 - 05/2009
6	Biomarkers (Surrogate Marker)IBA 01/2022 - 09/2016
6	Fluorouracil (Carac)FDA LinkGeneric 04/2021 - 05/2009
5	PlatinumIBA 01/2020 - 05/2018
5	Genetic Markers (Genetic Marker)IBA 01/2020 - 09/2017
5	Leucovorin (Folinic Acid)FDA Link 11/2019 - 05/2009
4	Proteins (Proteins, Gene)FDA Link 01/2022 - 05/2018
4	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2018 - 05/2015
2	Pregnane X ReceptorIBA 04/2021 - 01/2016
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2020 - 05/2015
2	Cell-Free Nucleic AcidsIBA 01/2020 - 11/2019
2	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 11/2019
2	Epidermal Growth Factor (EGF)IBA 01/2020 - 05/2015
2	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 01/2019 - 01/2016
2	CytokinesIBA 01/2019 - 01/2018
2	EnzymesIBA 06/2017 - 09/2008
1	Tumor Biomarkers (Tumor Markers)IBA 01/2022
1	palbociclibIBA 09/2020
1	ribociclibIBA 09/2020
1	abemaciclibIBA 09/2020
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 09/2020
1	Sorafenib (BAY 43-9006)FDA Link 01/2020
1	Chimeric Antigen ReceptorsIBA 01/2020
1	Imatinib Mesylate (Gleevec)FDA Link 01/2020
1	Cetuximab (Erbitux)FDA Link 01/2020
1	Bevacizumab (Avastin)FDA Link 01/2020
1	afliberceptIBA 01/2020
1	AntigensIBA 01/2020
1	Mitogen-Activated Protein KinasesIBA 01/2020
1	Tyrosine Kinase InhibitorsIBA 01/2020
1	Immune Checkpoint InhibitorsIBA 01/2020
1	Panitumumab (Vectibix)FDA Link 01/2020
1	Estrogens (Estrogen)FDA Link 01/2020
1	RamucirumabIBA 01/2020
1	AntibodiesIBA 01/2020
1	taxaneIBA 01/2020
1	CateninsIBA 11/2019
1	Telomerase (Telomerase Reverse Transcriptase)IBA 11/2019
1	Carboplatin (JM8)FDA LinkGeneric 10/2019
1	Ribosomal Proteins (Ribosomal Protein)IBA 10/2019
1	Paclitaxel (Taxol)FDA LinkGeneric 10/2019
1	Circulating Tumor DNAIBA 07/2017
1	HLA-G Antigens (HLA G)IBA 06/2017
1	3' Untranslated Regions (3' UTR)IBA 06/2017
1	MicroRNAs (MicroRNA)IBA 04/2016
1	Hepatocyte Nuclear FactorsIBA 01/2016
1	Constitutive Androstane ReceptorIBA 01/2016
1	Intergenic DNA (Junk DNA)IBA 01/2016
1	Folic Acid (Vitamin M)FDA LinkGeneric 05/2015
1	Biological ProductsIBA 05/2015
1	Finasteride (Propecia)FDA LinkGeneric 12/2014
1	5-alpha Reductase InhibitorsIBA 12/2014
1	thiamine triphosphorate (TTP)IBA 05/2009
1	prolyl-proline (Pro-Pro)IBA 05/2009
1	arginylarginine (Arg-Arg)IBA 05/2009
1	Folic Acid AntagonistsIBA 09/2008

Therapy/Procedure

9	Therapeutics 06/2022 - 05/2015
7	Neoadjuvant Therapy 01/2022 - 05/2009
5	Drug Therapy (Chemotherapy) 04/2021 - 05/2009
3	Radiotherapy 01/2020 - 04/2016
2	Precision Medicine 07/2017 - 01/2016
1	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2020
1	Adjuvant Chemoradiotherapy 01/2020
1	Adjuvant Chemotherapy 10/2019
1	Liver Transplantation 08/2019
1	Immunotherapy 07/2017